Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guillaume Auzac"'
Autor:
Anna Gueiderikh, Thomas Sarrade, Youlia Kirova, Brigitte De La Lande, Florent De Vathaire, Guillaume Auzac, Anne Laure Martin, Sibille Everhard, Nicolas Meillan, Celine Bourgier, Ahmed Benyoucef, Thomas Lacornerie, David Pasquier, Séverine Racadot, Alexandra Moignier, François Paris, Fabrice André, Eric Deutsch, Boris Duchemann, Rodrigue Setcheou Allodji, Sofia Rivera
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeRadiation-induced lung injury (RILI) is strongly associated with various clinical conditions and dosimetric parameters. Former studies have led to reducing radiotherapy (RT) doses to the lung and have favored the discontinuation of tamoxifen d
Externí odkaz:
https://doaj.org/article/ea5a25b9b3ba4c42aa9f597be8748f8c
Autor:
Rémi Bourdais, Samir Achkar, Charles Honoré, Matthieu Faron, Andrea Cavalcanti, Guillaume Auzac, Carine Ngo, Leila Haddag-Miliani, Benjamin Verret, Sarah Dumont, Eric Deutsch, Axel Le Cesne, Olivier Mir, Cécile Le Péchoux, Antonin Levy
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 29, Iss , Pp 79-84 (2021)
Aim: To prospectively assess toxicities of curative-intent intensity-modulated conformal radiotherapy (IMRT) in patients with extremity soft tissue sarcomas (ESTS). Methods: Data from 59 consecutive patients with ESTS between 2014 and 2019 were both
Externí odkaz:
https://doaj.org/article/795fc0cca8cf4bf3a5e7347ebe06bd0f
Autor:
Thomas Sarrade, Rodrigue Allodji, Youssef Ghannam, Guillaume Auzac, Sibille Everhard, Youlia Kirova, Karine Peignaux, Philippe Guilbert, David Pasquier, Séverine Racadot, Céline Bourgier, Sandrine Ducornet, Fabrice André, Florent De Vathaire, Sofia Rivera
Publikováno v:
Cancers, Vol 15, Iss 3, p 751 (2023)
This article describes the methodology used and provides a characterization of the study population in CANTO-RT (CANcer TOxicities RadioTherapy). CANTO (NCT01993498) is a prospective clinical cohort study including patients with stage I-III BC from 2
Externí odkaz:
https://doaj.org/article/0014870fb4534161a2f1797b759bb843
Autor:
Alicia Le Bras, Yazid Belkacemi, céline Bourgier, Isabelle Gabelle-Flandin, Adeline Petit, Philippe Guilbert, Julien Geffrelot, Christian Carrie, Eleonor RIVIN DEL CAMPO, Chantal Hanzen, claire charra-brunaud, Guillaume Auzac, Thomas Lacornerie, Jérôme Lemonnier, Eric Lartigau, Isabelle Durand-Zaleski
Publikováno v:
Cancer Research. 83:P1-10
Purpose: The economic evaluation reports the incremental cost utility ratio and budget impact of APBI vs standard external beam WBI for the treatment of post-menopausal women with early stage breast cancer. Methods and materials: We compared 488 wome
Autor:
Yazid Belkacemi, Isabelle Gabelle-Flandin, Marie-Cécile Le Deley, Adeline Petit, Philippe Guilbert, Julien Geffrelot, Christian Carrie, Eleonor Rivin Del Campo, Chantal Hanzen, Claire Charra-Brunaud, Isabelle Lecouillard, Nicolas Magne, Agnès Tallet, Nicolas Leduc, Blaha Belgadi, Philippe Fourneret, Alexandre Coutte, Esther Capelo, Franck Darloy, Muriel Garcia Ramirez, Philippe Dudouet, Pierre Clavere, Jean-Philippe Suchaud, Guillaume Auzac, Thomas Lacornerie, Jérôme Lemonnier, Céline Bourgier, Eric Lartigau
Publikováno v:
Cancer Research. 83:PD3-05
Purpose: The aim of current analyses is to report toxicity and cosmetic outcomes at 3 and up to 9 years of follow-up of post-menopausal patients randomized to receive either standard external beam whole breast radiotherapy (WBI), including hypofracti
Autor:
Thomas Sarrade, Rodrigue Allodji, Youssef Ghannam, Guillaume Auzac, Sibille Everhard, Ophélie Querel, Youlia Kirova, Karine Peignaux, Philippe Guilbert, Claire Charra-Brunaud, Julien Blanchecotte, Rezart Belshi, David Pasquier, Séverine Racadot, Céline Bourgier, Sandrine Ducornet, David Gibon, Fabrice André, Florent De Vathaire, Sofia Rivera
Publikováno v:
Cancer Research. 82:P3-19
Purpose: In this paper, we describe the methodology used, and provide a first characterization of the study population and radiotherapy (RT) data in CANTO-RT (CANcer TOxicities Radiotherapy), the largest available multicenter prospective cohort of ea
Autor:
Youssef Ghannam, Antonio Di Meglio, Thomas Sarrade, Alexandra Jacquet, Sibille Everhard, Youlia Kirova, Karine Peigneaux, Philippe Guilbert, Claire Chara-Brunaud, Julien Blanchecotte, Gilles Crehange, David Pasquier, Séverine Racadot, Céline Bourgier, Julien Geffrelot, Ahmed Benyoucef, Francois Paris, Guillaume Auzac, Inès Vaz-Luis, Sofia Rivera
Publikováno v:
Cancer Research. 82:P4-11
Background Fatigue is a common and disabling symptom experienced by patients (pts) after breast cancer (BC) treatment, significantly impacting their quality of life. However, this complex and multidimensional symptom often remains poorly managed. Pre